Is DCPH or RYLD a better dividend investment in 2026?

DCPH currently yields 7.82% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between DCPH and RYLD?

DCPH has a forward dividend yield of 7.82% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 4.57 percentage points.

Home › Compare › DCPH vs RYLD

DCPH vs RYLD: Dividend Comparison 2026

DCPH yields 7.82% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $11.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DCPH

● Live price

7.82%

Share price

$25.59

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$33.6K

Annual income

$1,282.05

Full DCPH calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — DCPH vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DCPH	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DCPH + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DCPH pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DCPH

Annual income on $10K today (after 15% tax)

$664.32/yr

After 10yr DRIP, annual income (after tax)

$1,089.74/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, RYLD beats the other by $1,190.79/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DCPH + RYLD for your $10,000?

DCPH: 50%RYLD: 50%

100% RYLD50/50100% DCPH

Portfolio after 10yr

$39.4K

Annual income

$1,982.51/yr

Blended yield

5.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on DCPH right now

DCPH

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$26.32

+2.9% upside vs current

Range: $25.00 — $30.00

Altman Z

7.4

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DCPH buys

RYLD buys

No recent congressional trades found for DCPH or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDCPHRYLD

Forward yield	7.82%	12.39% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$33.6K	$45.3K ✓
Annual income after 10y	$1,282.05	$2,682.98 ✓
Total dividends collected	$10.4K	$19.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: DCPH vs RYLD ($10,000, DRIP)

Year	DCPH Portfolio	DCPH Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,482	$781.56	$11,939	$1,239.34	$457.00 → RYLD
2	$13,124	$838.64	$14,158	$1,382.89	$1.0K → RYLD
3	$14,938	$895.89	$16,682	$1,532.59	$1.7K → RYLD
4	$16,937	$953.05	$19,537	$1,687.64	$2.6K → RYLD
5	$19,133	$1,009.87	$22,752	$1,847.20	$3.6K → RYLD
6	$21,538	$1,066.15	$26,355	$2,010.43	$4.8K → RYLD
7	$24,167	$1,121.67	$30,376	$2,176.45	$6.2K → RYLD
8	$27,035	$1,176.26	$34,847	$2,344.43	$7.8K → RYLD
9	$30,158	$1,229.77	$39,800	$2,513.54	$9.6K → RYLD
10	$33,551	$1,282.05	$45,269	$2,682.98	$11.7K → RYLD

DCPH vs RYLD: Complete Analysis 2026

DCPH — Stock

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Full DCPH Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this DCPH vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DCPH vs SCHD DCPH vs JEPI DCPH vs O DCPH vs KO DCPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.